Roderick H. MacLeod - 07 Mar 2024 Form 4 Insider Report for NEVRO CORP

Role: Chief Financial Officer
Signature: /s/ Kashif Rashid, as Attorney-in-Fact for Roderick H. MacLeod
Issuer symbol: N/A
Transactions as of: 07 Mar 2024
Net transactions value: -$109,324
Form type: 4
Filing time: 11 Mar 2024, 16:50:26 UTC
Previous filing: 06 Mar 2024
Next filing: 30 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVRO	Common Stock	Award	$0	+84,326	+133%	$0.000000	147,840	07 Mar 2024	Direct	F1
transaction	NVRO	Common Stock	Tax liability	$109,324	-7,136	-4.8%	$15.32	140,704	07 Mar 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. 1/3rd of the RSUs will vest on March 7, 2025 and the remainder will vest quarterly thereafter, such that all RSUs will be fully vested by the third anniversary of the grant date, subject to the Reporting Person's continued service to the issuer.
F2	Includes 121,763 RSUs.

Content

Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. 1/3rd of the RSUs will vest on March 7, 2025 and the remainder will vest quarterly thereafter, such that all RSUs will be fully vested by the third anniversary of the grant date, subject to the Reporting Person's continued service to the issuer.

Includes 121,763 RSUs.